TW200706538A - Perfluoroalkyl-containing complexes, process for their production as well as their use - Google Patents

Perfluoroalkyl-containing complexes, process for their production as well as their use

Info

Publication number
TW200706538A
TW200706538A TW095125755A TW95125755A TW200706538A TW 200706538 A TW200706538 A TW 200706538A TW 095125755 A TW095125755 A TW 095125755A TW 95125755 A TW95125755 A TW 95125755A TW 200706538 A TW200706538 A TW 200706538A
Authority
TW
Taiwan
Prior art keywords
production
well
perfluoroalkyl
containing complexes
radiodiagnosis
Prior art date
Application number
TW095125755A
Other languages
English (en)
Chinese (zh)
Inventor
Heiko Schirmer
Hanns-Joachim Weinmann
Johannes Platzek
Ludwig Zorn
Bernd Misselwitz
Jorg Meding
Heribert Schmitt-Willich
Thomas Brumby
Original Assignee
Schering Ag
Epix Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag, Epix Pharm Inc filed Critical Schering Ag
Publication of TW200706538A publication Critical patent/TW200706538A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TW095125755A 2005-07-15 2006-07-14 Perfluoroalkyl-containing complexes, process for their production as well as their use TW200706538A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005033902A DE102005033902B3 (de) 2005-07-15 2005-07-15 Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel

Publications (1)

Publication Number Publication Date
TW200706538A true TW200706538A (en) 2007-02-16

Family

ID=37057146

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095125755A TW200706538A (en) 2005-07-15 2006-07-14 Perfluoroalkyl-containing complexes, process for their production as well as their use

Country Status (22)

Country Link
EP (1) EP1904463A2 (es)
JP (1) JP2009501174A (es)
KR (1) KR20080043762A (es)
CN (1) CN101223148A (es)
AR (1) AR054865A1 (es)
AU (1) AU2006272025A1 (es)
BR (1) BRPI0613407A2 (es)
CA (1) CA2615443A1 (es)
CR (1) CR9645A (es)
DE (1) DE102005033902B3 (es)
DO (1) DOP2006000167A (es)
EC (1) ECSP088100A (es)
GT (1) GT200600313A (es)
IL (1) IL187926A0 (es)
NO (1) NO20080813L (es)
PE (1) PE20070376A1 (es)
RU (1) RU2008105356A (es)
TN (1) TNSN08016A1 (es)
TW (1) TW200706538A (es)
UY (1) UY29664A1 (es)
WO (1) WO2007009638A2 (es)
ZA (1) ZA200801523B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007015598A1 (de) * 2007-03-29 2008-10-02 Heinrich-Heine-Universität Düsseldorf Verwendung von fluorhaltigen Verbindungen zu Diagnosezwecken mit Hilfe bildgebender Verfahren
CA2711426C (en) 2008-01-08 2018-05-22 Lantheus Medical Imaging, Inc. N-alkoxyamide conjugates as imaging agents
CA3153519A1 (en) * 2019-10-04 2021-04-08 Bryan J. Traughber Development of imaging and therapeutic glucose analogues for sodium dependent glucose transporters
EP4059925A1 (en) 2021-03-15 2022-09-21 Bayer Aktiengesellschaft New contrast agent for use in magnetic resonance imaging
CN114181164A (zh) * 2021-12-13 2022-03-15 武汉大学中南医院 基于Fe(Ⅱ)特异性MRI对比剂的合成方法及其应用
EP4335840A1 (en) 2022-09-09 2024-03-13 Bayer Aktiengesellschaft New contrast agents for use in diagnostic imaging
EP4335462A1 (en) 2022-09-09 2024-03-13 Bayer AG Contrast agents for use in diagnostic computed tomography imaging

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317588C2 (de) * 1993-05-24 1998-04-16 Schering Ag Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19744004C1 (de) * 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging
DE19744003B4 (de) * 1997-09-26 2004-07-08 Schering Ag Kontrastmittel für das Infarkt- und Nekroseimaging
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
DE10040858C2 (de) * 2000-08-11 2003-12-18 Schering Ag Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
ECSP088100A (es) 2008-05-30
EP1904463A2 (de) 2008-04-02
CR9645A (es) 2008-05-21
GT200600313A (es) 2007-04-23
DOP2006000167A (es) 2007-02-28
UY29664A1 (es) 2007-02-28
KR20080043762A (ko) 2008-05-19
PE20070376A1 (es) 2007-04-20
CA2615443A1 (en) 2007-01-25
WO2007009638A2 (de) 2007-01-25
NO20080813L (no) 2008-04-09
BRPI0613407A2 (pt) 2011-01-11
WO2007009638A3 (de) 2007-04-26
IL187926A0 (en) 2008-03-20
RU2008105356A (ru) 2009-08-20
AR054865A1 (es) 2007-07-25
DE102005033902B3 (de) 2007-04-05
TNSN08016A1 (en) 2009-07-14
ZA200801523B (en) 2008-11-26
CN101223148A (zh) 2008-07-16
JP2009501174A (ja) 2009-01-15
AU2006272025A1 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
TW200740777A (en) Perfluoroalkyl-containing complexes, process for their production as well as their use
TW200706538A (en) Perfluoroalkyl-containing complexes, process for their production as well as their use
MX2009012949A (es) Anticuerpos humanizados que enlazan a ab (1-42) globulomero y usos de los mismos.
MX2009002492A (es) Agentes que comprenden compuestos marcados con 18f y metodos relacionados.
IL180896A0 (en) Method of tumour imaging
TW200740844A (en) Novel MAdCAM antibodies
MX2007001035A (es) Metodo para producir una composicion, la composicion y su uso.
WO2011045415A3 (en) Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
MY153198A (en) Inhibitors of protein aggregation
EP2576578A4 (en) POLYMORPHES OF 2'-O-FUCOSYLLACTOSE AND MANUFACTURE THEREOF
WO2007044413A3 (en) Wwox gene, vectors containing the same, and uses in treatment of cancer
MX2012007041A (es) Quelados de manganeso y su uso como agentes de contraste en elaboracion de imagen de resonancia magnetica (mri).
MX2009012625A (es) Metodos para el tratamiento, diagnostico y deteccion de trastornos asociados con el fgf21.
WO2007016548A3 (en) Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer
MX2012004525A (es) Compuestos.
WO2007033167A3 (en) Compositions and methods for detecting and treating cancer
MX357227B (es) Nanoparticulas basadas en lipidos.
WO2012065045A3 (en) Development and screening of contrast agents for in vivo imagining of parkinson's disease
WO2008008786A3 (en) Pre- and intra- operative imaging of bladder cancer
MX2009009291A (es) Compuestos activos biologicamente marcados con fluoro-benzoilo 18f como agentes de diagnostico por imagenes asi como precursores de benzotriazol-1-iloxi-benzoilo, 2,5-dioxo-pirrolidin-1-iloxi benzoilo y trimetilamonio benzoilo.
WO2010032899A3 (en) Eno1-specific human antibody
HK1138571A1 (zh) 用於診斷成像和放射治療的葉酸軛合物和相應的金屬螯合物絡合物
MY155340A (en) Use of cathepsin c
WO2016154542A3 (en) Compositions and methods for treating cardiovascular related disorders
MY148553A (en) Metal chelates having a perfluorinated peg radical, processes for their preparation, and their use